Digma Medical, Ltd.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Request demo

Digma Medical, Ltd. - overview

About

Founded in 2013 and based in Israel, Digma Medical, Ltd. operates as a clinical-stage medical device company developing a novel endoscopic treatment for metabolic diseases. Irit Yaniv and Ilan Ben-Oren (CTO) are the co-founders of the company. Digma Medical, Ltd.

raised venture funding from Peregrine Ventures. The company specializes in advancing the treatment of type 2 diabetes. The firm addresses the treatment through its endoscopic glycemic management (EGM) therapy. This invasive treatment focuses on the duodenal submucosa, a critical area for nutrient sensing and metabolic signaling, to restore the body’s natural ability to control blood glucose levels.

The EGM procedure involves a console and a single-use catheter compatible with standard gastrointestinal endoscopes, allowing it to be performed in a regular GI endoscopy suite without additional imaging equipment. EGM helps patients with durable improvements in glycemic control, minimal side effects, and reduced reliance on daily medications.

Current Investors

Peregrine Ventures

Request a demo

Primary Industry

Medical Devices & Equipment

Sub Industries

Surgical Devices

Website

www.digmamedical.com/

Verticals

Manufacturing

Company Stage

Series A

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.

Request demo